Concepedia

Barbara Shepherd

BS

10

Publications

617

Citations

10

H-Index

1984

Active since

Affiliations

Aeras(Current)

South African Tuberculosis Vaccine Initiative

University of Cape Town

TuBerculosis Vaccine Initiative

Statens Serum Institut

Barbara Shepherd is an author at Aeras specializing in medicine, gene expression, and developmental genetics.

Top concepts

Publications per year

1984–2018

10

Publications

10

A tissue-specific transcription enhancer from the Drosophila yolk protein 1 gene

Michael J. Garabedian, Barbara Shepherd, Pieter C. Wensink · Cell · 1986 · 189 citations

, , +11

Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial

Sara Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 112 citations

A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants

Michèle Tameris, David A. Hokey, Videlis Nduba et al. · Vaccine · 2015 · 64 citations

, , +8

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial

Daniel F. Hoft, Azra Blazevic, Asmir Selimovic et al. · EBioMedicine · 2016 · 59 citations · Full text

Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials

Maria Norrby, Timo Vesikari, Lars Lindqvist et al. · Vaccine · 2017 · 51 citations · Full text

Rows per page

1–5 of 10